Pune, India, Feb. 07, 2022 (GLOBE NEWSWIRE) -- The global hormone replacement therapy market size was USD 13.40 billion in 2020. The market is projected to grow from USD 14.17 billion in 2021 to USD 21.49 billion in 2028 at a CAGR of 6.1% in the 2022-2028 period. This information is provided by Fortune Business Insights, in its report titled, “Hormone Replacement Therapy Market, 2022-2028.”
According to our expert analysts, the market is witnessing growth, owing to its development in several other hormone-associated illnesses concerned with diverse age groups that are impacting both, women as well as men.
Industry Developments:
May 2021: Myovant Sciences GmbH declared that it gained sanction from the U.S. FDA for hormone therapy Myfembree as a treatment for uterine fibroid bleeding. The drug unveiled by Myovant is set to give uninterrupted competition to Abbvie with an extra dosing benefit.
Request a Sample Copy of the Research Report
Unveiling of Radical Drug Delivery Systems with Spurred Efficiency to Drive Market Growth
Hormone replacement therapy is vital for patients with growth hormone scarcities, women experiencing menopausal conditions, elderly population having hypogonadism, and other patients. The treatment is obtainable in several forms, which involve skin and buccal patches, injectable, and tablets, and others.
Attributed to the increase in implementation of these products across the world, numerous manufacturers are emphasizing on the development of the progressive drug delivery systems such as vaginal estrogen drugs as well as transdermal estrogen patches. This is expected to bolster the hormone replacement therapy market growth.
To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:
https://www.fortunebusinessinsights.com/hormone-replacement-therapy-hrt-market-102543
Therapy Type, Indication, Route of Administration, Distribution Channel, and Region are studied for the Market
On the basis of therapy type, the market is segregated into estrogen and combination replacement therapy, growth hormone replacement therapy, thyroid hormone replacement therapy, and testosterone hormone replacement therapy. Estrogen and combinations hormone replacement therapy led the market growth, owing to augmentation in the consciousness linked with menopause symptoms across the world.
Based on indication, the market is classified into menopause, hypothyroidism, male hypogonadism, and growth hormone deficiency.
On the basis of route of administration, the hormone replacement market is categorized into oral, transdermal, and parenteral.
In terms of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies & stores, and online pharmacies.
Geographically, the global market is branched into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Report Coverage:
The report offers a holistic evaluation of the hormone replacement therapy market along with present trends and forthcoming expectations to launch approximate investment profits. Moreover, a detailed examination of any forthcoming opportunities, threats, competitions or driving aspects is also conversed in the report. Step by step, methodical regional review is offered in the report.
COVID-19 influences have been added to the report to aid investors and business owners to perceive an amplified knowledge of the existing threats. The key players in the market are distinguished, and their tactics to bolster the market growth are mentioned in the report.
Quick Buy Hormone Replacement Therapy Market
https://www.fortunebusinessinsights.com/checkout-page/102543
Regional Insights:
The market in North America was worth USD 7.07 billion in 2020 and held the maximum hormone replacement therapy market share. Moreover, the market is anticipated to lead the global market, owing to an increase in the occurrence of menopause and growth hormone scarcity illnesses.
Europe is the second dominant region, owing to an escalation in the hormonal conditions in women experiencing menopausal symptoms, older people undergoing hypothyroidism, and increase in growth hormone ailments.
Asia Pacific is projected to appear as one of the biggest suppliers of the product coupled with the highest CAGR in future.
Competitive Landscape:
Principal Companies to Grasp Effective Tactics and Expand their Market Presence
Medical companies operate fundamentally on the importance of the product and its demand in the market. Additionally, to uplift their market size & share, and to attain a competitive benefit, numerous dominating players are engaged in several tactical deals to promote the brand and elevate their sales.
List of Key Players Mentioned in the Report:
- Novo Nordisk A/S (Bagsværd, Denmark)
- Pfizer Inc. (New York, U.S.)
- AbbVie’s (Lake Bluff, U.S.)
- Merck KGaA (Dermstadt, Germany)
- Endo International plc (Dublin, Ireland)
- Allergan plc (Irvine, U.S.)
- Eli Lilly and Company (Indianapolis, U.S.)
- Mithra Pharmaceuticals (Liege, Belgium)
- Amgen (Thousand Oaks, U.S.)
Have Any Query? Ask Our Experts
Table Of Content
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Trends
- Key Insights
- Pipeline Analysis
- Key Industry Developments - Mergers, Acquisitions, and Collaborations
- New Product Launches
- Impact of COVID-19 on Global Hormone Replacement Therapy Market
- Key Market Trends
- Global Hormone Replacement Therapy Market Analysis, Insights and Forecast, 2017-2028
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Therapy Type
- Estrogen and Combinations Replacement Therapy
- Thyroid Hormone Replacement Therapy
- Growth Hormone Replacement Therapy
- Testosterone Hormone Replacement Therapy
- Market Analysis, Insights and Forecast – By Indication
- Menopause
- Hypothyroidism
- Male hypogonadism
- Growth hormone deficiency
- Market Analysis, Insights and Forecast – By Route of Administration
- Oral
- Transdermal
- Parenteral
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospitals Pharmacies
- Retail Pharmacies & Stores
- Online Pharmacies
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
ToC Continue…!
Get your Customized Research Report:
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email:sales@fortunebusinessinsights.com
